April 2014
In This Issue
Stay Connected

Like us on FacebookFollow us on TwitterView our profile on LinkedIn
A Note from Jennifer
Dear WIPO Re:Search Members and Friends, 


Spring has sprung busier than ever for BVGH and WIPO Re:Search. Four new collaborations between Members were finalized.
If you haven't already done so, please visit our website to download a copy of the 2012-2013 WIPO Re:Search Partnership Stories and the 2013 Partnership Hub Annual Report. 
I am extremely pleased to welcome our three newest Members, the National University of Singapore, the National Institute of Parasitic Diseases, Chinese CDC, and Salvensis. Each organization participates in cutting-edge neglected disease research and brings abundant collaboration opportunities to WIPO Re:Search.


As always, please forward this Snapshot to your colleagues and reach out to us with any partnering requests or ideas. 


 Jennifer Dent

President, BVGH 


SpecialSave the Date - 2014 WIPO Re:Search Annual Meeting

The WIPO Re:Search Annual Meeting will be held in New York City this year. The Meeting is scheduled to coincide with the 27th International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Assembly and is tentatively set for November 6th. Stay tuned for updates as the event draws nearer.
noticeSpecial Notice

The 2014 Biotechnology Industry Organization (BIO) International Convention will be held June 23-26, in San Diego, California. This year's Convention will feature several fora, such as the Emerging Opportunities in Global Markets Forum: Africa and The Changing Landscape of Industry's Engagement in Global Health, that will include important discussions regarding the healthcare needs of the developing world. The Convention will provide the opportunity to engage industry leaders and budding start-ups in discussions about the necessity and feasibility of products for diseases of poverty and to raise global awareness of these diseases' devastating effects.
statsWIPO Re:Search Statistics


Four new collaborations were finalized this month, including: 
The University of British Columbia (UBC) will provide Swiss Tropical and Public Health Institute (Swiss TPH) with a selection of avermectins to screen against M. ulcerans, the causative agent of Buruli ulcer. 
PHCPartnership Hub Central 



  Christian Agyare, Senior Lecturer, Faculty of Pharmacy & Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, is one of the five African scientists who have participated in sabbatical opportunities at WIPO Re:Search Members' locations. Christian was hosted by Conor Caffrey, Schistosomiasis and Hookworm Core Director, Center for Discovery and Innovation in Parasitic Diseases, University of California, San Francisco (UCSF). During the first stage of his  visit, Christian screened small molecules and natural products against several pathogenic parasites. A video interview of Christian is available on WIPO's YouTube channel. 




memberNew Members Announcement

We are pleased to announce that the National University of Singapore (NUS), the National Institute of Parasitic Diseases (NIPD), Chinese CDC, and Salvensis have joined WIPO Re:Search.
The National University of Singapore is an institution considered to be among the best in the world. Its faculty members study numerous topics of importance to global health, including the development of mucosal dengue vaccines and tuberculosis chemotherapies.
Located in Shanghai, China, the National Institute of Parasitic Diseases, Chinese CDC, has been a WHO Collaborating Center for malaria, schistosomiasis, and filariasis for 30 years. Research at NIPD also includes projects focusing on soil-transmitted helminthiases and leishmaniasis. 
Salvensis is a nonprofit drug discovery company focused on rare and neglected diseases. The organization, which is located in Sandwich, UK is currently working to discover new and improved drugs to treat schistosomiasis.
RequestResearch Request
GlaxoSmithKline, in partnership with its Tres Cantos Open Lab Foundation (TCOLF) and funding from the European Commission, has announced the establishment of its new Open Lab Cofund Fellowship Program. The program seeks to provide experienced researchers with the opportunity to develop research projects at GSK's facilities in Tres Cantos, Spain, which includes support from GSK's staff and access to its resources. For more information, visit the TCOLF Cofund page. The next application deadline is June 25th, 2014. 
HCHighlighted Contributions  
Featured this month are two contributions submitted by the Kenya Agricultural Research Institute (KARI), Trypanosomiasis Research Centre to the WIPO Re:Search Database.
The Trypanosomiasis Research Centre (TRC) maintains significant animal testing facilities, including the capacity to hold up to 150 primates. TRC is looking to enter into collaborative partnerships, including contract research, for organizations wishing to undertake in vivo pre-clinical studies into the safety and toxicity of drug candidates and diagnostic tools, using its primate models. 
The TRC is looking to develop partnerships with interested parties wishing to gain access to its comprehensive parasite bank, for the purposes of genetic sequencing and / or the development of new diagnostic tools and vaccines. The bank contains all human trypanosomes, all animal parasites, and DNA from trypanosome vectors. 


For more information or to discuss potential collaborations regarding this technology, please contact Roopa Ramamoorthi.  

EventsTableUpcoming Global Health Events

Event Title
Web Link
May 12-15
10th BioMalPar - Biology and Pathology of the Malaria Parasite
Heidelberg, Germany
June 8-13
Molecular Mechanisms of Pathogenesis and Treatment of Parasitic Diseases
Newport, RI
Jun 30 - July 2
Seventh EDCTP Forum - The Partnership Journey: New Horizon for Better Health
Berlin, Germany

Are you attending a global health event?
Do you have a Research Request to highlight in the Snapshot?

We want to hear from you! Please send feedback and suggestions via email.

WIPO Re:Search Pharmaceutical Members
 *known as Merck in the US and Canada

Copyright © 2012. All Rights Reserved.